CVS, Wal­greens and Wal­mart reach near­ly $12B set­tle­ment over opi­oid epi­dem­ic

Top phar­ma­cy chains CVS Health, Wal­greens and Wal­mart are look­ing to bun­dle the bulk of their opi­oid-re­lat­ed lit­i­ga­tion in­to a ma­jor set­tle­ment an­nounced to­day.

CVS said in its earn­ings re­port that it agreed to pay more than $5 bil­lion to states, tribes and oth­er groups over the next decade to sub­stan­tial­ly re­solve all opi­oid-re­lat­ed law­suits and claims against the com­pa­ny. Wal­greens sim­i­lar­ly said in an SEC fil­ing that it would pay $4.8 bil­lion in re­me­di­a­tion pay­ments over 15 years to a ma­jor­i­ty of these suits.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters